renal disease Archives
Kidney diseases research collaboration renewed
Oct. 6, 2022—Vanderbilt University Medical Center and Bayer have agreed to continue a strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases.
Analysis seeks to better manage infection in dialysis patients
Apr. 1, 2021—Analysis seeks to better manage infection in dialysis patients
Implant one day may replace dialysis
May. 18, 2020—Vanderbilt researchers used pharmacological manipulations to increase salt and water transport by kidney cells grown in culture, a step necessary for realizing an implantable artificial kidney device.
International Society of Nephrology honors Fogo
May. 2, 2019—Agnes Fogo, MD, an internationally known expert in kidney disease at Vanderbilt University Medical Center, has won the 2019 Roscoe Robinson Award from the International Society of Nephrology (ISN).
Surprising finding in the kidney
Apr. 16, 2015—TGF-beta signaling in the kidney was thought to be a target for reducing renal fibrosis, but Vanderbilt researchers report that fibrosis still occurs in the absence of TGF-beta signaling.
Study tracks new end-stage renal disease therapy
Aug. 7, 2014—Researchers in Vanderbilt’s Division of Nephrology conducted a Phase 3 clinical trial to test the safety and efficacy of a new drug to treat patients with end-stage renal disease.